BS:BLAU3 Blau Farmacêutica S.A

Blau Farmacêutica S.A., a pharmaceutical company, engages in the production and sale of biological medications in the United States, Colombia, Chile, Peru, Argentina, Uruguay, and Brazil. The company's medications cover various therapeutic classes, such as oncology, hematology, nephrology, rheumatology, infectiology, anesthesiology, intensive care, general practice, and others. Its medications also comprise uterine stimulator, antibiotics, feminine health care, biopharmaceuticals, essential hospital products, antivirals and antiretrovirals, biosimilars, acid pump inhibitor, hemoderivados, antithrombotic, and trombolíticos. The company was founded in 1987 and is headquartered in Cotia, Brazil.

26.26 BRL
As of 03/22/2023

Security Information
Category1:  Global Equity
Category2:  Comon stocks
Category3:  Emerging markets
GICS sector:  Health Care
Index country:  Brazil
Country of incorporation:  
IPO date:  04/19/2021
Stock exchange:    XBSP
Exchange country:   Brazil
Market cap:   4,276,248,064 BRL
Current dividend yield:   2.54%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy